Cerafil at Gloster Metals

Autor: Cerel Ltd, Coventry Road, Uk. Tel, Hinckley, Leics. Le Jt, Catherine House

Publikováno v: Filtration & Separation. 29:364

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ebe3d0129fa2658dcc5a67e8eb2c3ca
https://doi.org/10.1016/0015-1882(92)80183-j

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Autor: Skoulidis F; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. fskoulidis@mdanderson.org., Araujo HA; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do MT; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qian Y; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun X; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cobo AG; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Le JT; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montesion M; Foundation Medicine, Cambridge, MA, USA., Palmer R; Pionyr Immunotherapeutics, South San Francisco, CA, USA., Jahchan N; Pionyr Immunotherapeutics, South San Francisco, CA, USA., Juan JM; D2G Oncology, Mountain View, CA, USA., Min C; Tango Therapeutics, Boston, MA, USA., Yu Y; Tango Therapeutics, Boston, MA, USA., Pan X; Tango Therapeutics, Boston, MA, USA., Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vokes N; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schmidt ST; Department of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Molkentine D; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Owen DH; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA., Memmott R; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA., Patil PD; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Marmarelis ME; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Murray JC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hellyer JA; Department of Genetics, Stanford University, Stanford, CA, USA., Gainor JF; Massachussetts General Hospital, Boston, MA, USA., Dimou A; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Bestvina CM; Department of Medicine, University of Chicago, Chicago, IL, USA., Shu CA; Columbia University, New York, NY, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Blakely CM; University of California San Francisco, San Francisco, CA, USA., Pecot CV; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Mezquita L; Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain., Tabbó F; Ospedale Michele e Pietro Ferrero, Cuneo, Italy., Scheffler M; Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany., Digumarthy S; Department of Radiology, Massachussetts General Hospital, Boston, MA, USA., Mooradian MJ; Massachussetts General Hospital, Boston, MA, USA., Sacher AG; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Lau SCM; Department of Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA., Saltos AN; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Rotow J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Johnson RP; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu C; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stewart T; Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Goldberg SB; Yale School of Medicine, New Haven, CT, USA., Killam J; North Shore University Hospital, Manhasset, NY, USA., Walther Z; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Schalper K; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Davies KD; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Woodcock MG; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Marrone KA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Forde PM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cummings AL; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Goldman JW; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Shaish H; Columbia University, New York, NY, USA., Kier M; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Katz S; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Aggarwal C; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Ni Y; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Azok JT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Segal J; Department of Pathology, University of Chicago, Chicago, USA., Ritterhouse L; Foundation Medicine, Cambridge, MA, USA., Neal JW; Department of Genetics, Stanford University, Stanford, CA, USA., Lacroix L; Institut Gustave Roussy, Villejuif, France., Elamin YY; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Negrao MV; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Le X; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lam VK; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Lewis WE; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kemp HN; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter B; Department of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Swisher S; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee R; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhou T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Poteete A; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kong Y; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takehara T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Paula AG; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parra Cuentas ER; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Behrens C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Blumenschein GR; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gay C; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Byers LA; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gibbons DL; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tsao A; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bivona TG; University of California San Francisco, San Francisco, CA, USA., Camidge DR; University of Colorado Cancer Center, Denver, CO, USA., Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Lieghl N; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Levy B; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Brahmer JR; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Garassino MC; Department of Medicine, University of Chicago, Chicago, IL, USA., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Garon EB; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Rizvi NA; Synthekine, Menlo Park, CA, USA., Scagliotti GV; University of Turin, Orbassano, Italy., Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany., Planchard D; Institut Gustave Roussy, Villejuif, France., Besse B; Institut Gustave Roussy, Villejuif, France., Herbst RS; Yale School of Medicine, New Haven, CT, USA., Wakelee HA; Department of Genetics, Stanford University, Stanford, CA, USA., Pennell NA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Shaw AT; Novartis Institute for Biomedical Research, Cambridge, MA, USA., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Carbone DP; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA., Hellmann MD; AstraZeneca, Gaithersburg, MD, USA., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Albacker L; Foundation Medicine, Cambridge, MA, USA., Mann H; AstraZeneca, Cambridge, UK., Zhu Z; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Cambridge, UK., Stewart R; AstraZeneca, Cambridge, UK., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland., Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA., Wong KK; Division of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA., Huang A; Tango Therapeutics, Boston, MA, USA., Winslow MM; D2G Oncology, Mountain View, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA., Rosen MJ; D2G Oncology, Mountain View, CA, USA., Winters IP; D2G Oncology, Mountain View, CA, USA., Papadimitrakopoulou VA; Pfizer, New York, NY, USA., Cascone T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jewsbury P; AstraZeneca, Cambridge, UK., Heymach JV; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jheymach@mdanderson.org.

Publikováno v: Nature [Nature] 2024 Nov; Vol. 635 (8038), pp. 462-471. Date of Electronic Publication: 2024 Oct 09.

Listening Sessions to Shape the Innovative NIH ComPASS Common Fund Program to Advance Health Equity.

Autor: Brown AGM; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Winchester D; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Bynum SA; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Amolegbe SM; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Ferguson YO; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Flournoy Floyd M; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Lawhorn C; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Le JT; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Lloyd J; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Oh AY; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Tyus N; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Whitaker DE; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript., Boyce CA; Alison G. M. Brown is with the National Heart Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD. Danyelle Winchester is with the Office of Science Policy, NIH. Shalanda A. Bynum is with the National Institute of Nursing Research, NIH. Sara M. Amolegbe, Nadra Tyus, and Cheryl Anne Boyce are with the Office of Strategic Coordination-The Common Fund, NIH. Yvonne O. Ferguson was with the Office of Strategic Coordination?The Common Fund, NIH, during the listening sessions and writing of the manuscript. Minnjuan Flournoy Floyd is with the National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Collene Lawhorn is with the National Institute of Mental Health, NIH. Jimmy T. Le is with the National Eye Institute, NIH. Jacqueline Lloyd is with the Office of Disease Prevention, NIH. April Y. Oh is with the National Cancer Institute, NIH. Damiya E. Whitaker is with the National Institute on Alcohol Abuse and Alcoholism, NIH, and was with the Office of Research on Women's Health, NIH, during the listening sessions and writing of the manuscript.

Publikováno v: American journal of public health [Am J Public Health] 2024 Jul; Vol. 114 (7), pp. 685-689. Date of Electronic Publication: 2024 Apr 18.

SanPy: Software for the analysis and visualization of whole-cell current-clamp recordings.

Autor: Guarina L; Department of Physiology & Membrane Biology, University of California-Davis School of Medicine, Davis, California., Le JT; Department of Physiology & Membrane Biology, University of California-Davis School of Medicine, Davis, California., Griffith TN; Department of Physiology & Membrane Biology, University of California-Davis School of Medicine, Davis, California., Santana LF; Department of Physiology & Membrane Biology, University of California-Davis School of Medicine, Davis, California., Cudmore RH; Department of Physiology & Membrane Biology, University of California-Davis School of Medicine, Davis, California. Electronic address: rhcudmore@ucdavis.edu.

Publikováno v: Biophysical journal [Biophys J] 2024 Apr 02; Vol. 123 (7), pp. 759-769. Date of Electronic Publication: 2024 Feb 27.